Showing 4,461 - 4,480 results of 7,331 for search 'significantly ((((we decrease) OR (larger decrease))) OR (linear decrease))', query time: 0.56s Refine Results
  1. 4461

    Table 7_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  2. 4462

    Table 4_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  3. 4463

    Table 1_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  4. 4464

    Table 3_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  5. 4465

    Table 5_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  6. 4466

    Table 8_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  7. 4467

    Table 2_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  8. 4468

    Table 6_Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021.xlsx by Chengwei Zhan (18872651)

    Published 2024
    “…The burden of GC was significantly higher in males compared to females. In addition, we found that the highest incidence and prevalence in females was in the age group of 75-79 years, whereas the highest incidence and prevalence in males was in the age group of 70-74 years.…”
  9. 4469

    Data Sheet 1_Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways.pdf by Marc Terrones (18094462)

    Published 2024
    “…When comparing ROS1+ tumor versus cell line transcriptomes, an upregulation of MYC and MET was found in cell lines together with a significantly decreased expression of HER3, HER4 and BRAF. …”
  10. 4470

    Table 1_Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways.xlsx by Marc Terrones (18094462)

    Published 2024
    “…When comparing ROS1+ tumor versus cell line transcriptomes, an upregulation of MYC and MET was found in cell lines together with a significantly decreased expression of HER3, HER4 and BRAF. …”
  11. 4471

    Image 10_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

    Published 2025
    “…Additionally, we evaluated tumor growth and immune cell infiltration using syngeneic mouse models.…”
  12. 4472

    DataSheet8_Refining dual RNA-seq mapping: sequential and combined approaches in host-parasitic plant dynamics.csv by Carmine Fruggiero (20143830)

    Published 2024
    “…However, it has to deal with issues related to multiple mapping and cross-mapping of reads in host and parasite genomes, particularly as evolutionary divergence decreases. In this paper, we evaluated the feasibility of this technique by simulating interactions between parasitic and host plants and refining the mapping process. …”
  13. 4473

    Image 3_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

    Published 2025
    “…Additionally, we evaluated tumor growth and immune cell infiltration using syngeneic mouse models.…”
  14. 4474

    Image 7_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.tif by Chen Wang (88408)

    Published 2025
    “…Additionally, we evaluated tumor growth and immune cell infiltration using syngeneic mouse models.…”
  15. 4475

    Table 6_Integrated analysis of microbiome and metabolome reveals insights into cervical neoplasia aggravation in a Chinese cohort.xlsx by Qingzhi Zhai (21265412)

    Published 2025
    “…Furthermore, we found a significant correlation between the cervical microbiota Porphyromonas and the metabolite PGE2, suggesting a potential role of key microbiota in inducing inflammation.…”
  16. 4476

    Image 6_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

    Published 2025
    “…Additionally, we evaluated tumor growth and immune cell infiltration using syngeneic mouse models.…”
  17. 4477

    GI variables of single-task versus dual-task. by Angeloh Stout (21755757)

    Published 2025
    “…We found that dual-task conditions significantly affected both gait initiation and sit-to-walk patterns, increasing the duration of transitions and mediolateral center of mass displacements, while reducing vertical center of mass displacements and forward propulsion. …”
  18. 4478

    Image 8_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

    Published 2025
    “…Additionally, we evaluated tumor growth and immune cell infiltration using syngeneic mouse models.…”
  19. 4479

    Image 1_Integrated analysis of microbiome and metabolome reveals insights into cervical neoplasia aggravation in a Chinese cohort.tif by Qingzhi Zhai (21265412)

    Published 2025
    “…Furthermore, we found a significant correlation between the cervical microbiota Porphyromonas and the metabolite PGE2, suggesting a potential role of key microbiota in inducing inflammation.…”
  20. 4480

    Image 15_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.jpeg by Chen Wang (88408)

    Published 2025
    “…Additionally, we evaluated tumor growth and immune cell infiltration using syngeneic mouse models.…”